Lobbying client · LD-2 disclosures
Cempra Pharmaceuticals Inc.
North Carolina
15 filings from 2 registrants · 2008–2011 · latest filed Apr 20, 2011
Reported on its behalf
$395K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$395K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
9 filings
$395K on those filings
Budget/Appropriations
BUD
1 filing
Medical/Disease Research/Clinical Labs
MED
Who did the lobbying
Every lobbyist named on this client's filings.
- James P Fabiani Fabiani & Company7 filingsthrough 2009
- Erin Fry Fabiani & Company7 filingsthrough 2009
- Stephen R Conafay Fabiani & Company7 filingsthrough 2009
- Melissa Dupree Fabiani & Company4 filingsthrough 2010
- Joel Johnson Fgs Global (US) LLC (Fka Fgh Holdings LLC)Covered position: Communications3 filings
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: cempra-pharmaceuticals-inc.